Wilman Luk
Wilman Luk publishes mostly in Molecular Biology, Physiology and Radiology, Nuclear Medicine and Imaging, on topics such as Alzheimer's disease research and treatments, Monoclonal and Polyclonal Antibodies Research and Glycosylation and Glycoproteins Research.
- World rank
- #1,180,545 of 7,710,434 ranked researchers
- Rank in Switzerland
- #19,982 of 80,918
- Works
- 15
- Citations
- 2.9k
- Citations per work
- 190.9
What does Wilman Luk research?
Wilman Luk's work is mostly in Medicine (36%), Biochemistry, Genetics and Molecular Biology (29%), Immunology and Microbiology (7%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences535.8%
- Medicine535.8%
- Life Sciences535.7%
- Everything else428.5%
- 1Molecular Biology29% of their works
- 2Physiology14% of their works
- 3Radiology, Nuclear Medicine and Imaging12% of their works
- 4Immunology7% of their works
- 5Oncology5% of their works
- 6Pathology and Forensic Medicine5% of their works
Research topics
- Alzheimer's disease research and treatments
- Monoclonal and Polyclonal Antibodies Research
- Glycosylation and Glycoproteins Research
- Protein purification and stability
- Drug Transport and Resistance Mechanisms
- Cholinesterase and Neurodegenerative Diseases
- NF-κB Signaling Pathways
- Cellular transport and secretion
Which keywords describe Wilman Luk's research?
The keywords of their largest research topics: Glycosylation, Therapeutic Antibodies, Amyloid Hypothesis, Tau Pathology, Antibody Engineering, Fc Receptors, Cancer and Biopharmaceuticals.
- NF-?B
- Endocytosis
- Cholinesterase Inhibitors
- ATP-dependent Transporters
- Immune System
- Biopharmaceuticals
- Fc Receptors
- Tau Pathology
- Therapeutic Antibodies
- Glycosylation
- Amyloid Hypothesis
- Antibody Engineering
- Cancer
- Glycans
- Protein Aggregation
- Acetylcholinesterase
- Multidrug Resistance
- Membrane Fusion
- Signaling
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 19 words, with their numbers
- Glycosylation82 topics
- Therapeutic Antibodies82 topics
- Amyloid Hypothesis61 topic
- Tau Pathology61 topic
- Antibody Engineering51 topic
- Fc Receptors51 topic
- Cancer42 topics
- Biopharmaceuticals31 topic
- Glycans31 topic
- Immune System31 topic
- Protein Aggregation31 topic
- ATP-dependent Transporters21 topic
- Acetylcholinesterase21 topic
- Cholinesterase Inhibitors21 topic
- Multidrug Resistance21 topic
- Endocytosis11 topic
- Membrane Fusion11 topic
- NF-?B11 topic
- Signaling11 topic
Where does Wilman Luk work?
Wilman Luk's main affiliation in the publication record is Bioanalytica (Switzerland), Switzerland.
How many publications and citations does Wilman Luk have?
OpenAlex counts 15 works and 2,863 citations for Wilman Luk, an h-index of 12, ranking #1,180,545 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Wilman Luk. Posts are plain text and can be reported.